Speaker Details

Sewon Kang, MD, FAAD

Sewon Kang, MD, FAAD

SESSIONS

S028 Late-breaking Research: Session 1
Mar 8, 2025 • 9:00 AM - 12:00 PM • Chapin Theater - Level III
S040 Late-Breaking Research: Session 2
Mar 8, 2025 • 1:00 PM - 4:00 PM • Chapin Theater - Level III

DISCLOSURES

Allergan, Inc – Advisory Board(Honoraria); CeraVe/Valeante – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria); Estee Lauder – Advisory Board(Honoraria); Galderma USA – Advisory Board(Honoraria); Incyte Corporation – Data Safety Monitoring Board(Fees); Rapalogix Health – Advisory Board(Stock Options); Walgreens Boots Alliance, Inc. – Investigator(Grants/Research Funding);